MindWalk Holdings Corp. (HYFT) stock
HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30
$0.68−0.11 (-14.27%)
Close on Nov 20, 2026Market cap $31.97MP/E –Yield –
MindWalk gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
MindWalk's gross profit for the twelve months ending Jul 31, 2026 was C$9.87M, up 57.9% year over year. For fiscal 2026 it was C$9.15M, up 59.6% from the year before. The highest annual figure on record is C$11.56M in fiscal 2023.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | C$9.15M | +59.6% |
| FY2025 | Apr 30, 2025 | C$5.73M | +40.1% |
| FY2024 | Apr 30, 2024 | C$4.09M | -64.6% |
| FY2023 | Apr 30, 2023 | C$11.56M | +5.3% |
| FY2022 | Apr 30, 2022 | C$10.98M | -4.8% |
| FY2021 | Apr 30, 2021 | C$11.54M | +43.6% |
| FY2020 | Apr 30, 2020 | C$8.03M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | C$2.25M | +47.1% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | C$2.50M | +56.7% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | C$2.46M | +39.9% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | C$2.66M | +94.4% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | C$1.53M | +51.2% |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | C$1.59M | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | C$1.76M | -44.9% |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | C$1.37M | -53.7% |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | C$1.01M | -63.9% |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | -C$4.85M | -245.3% |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | C$3.20M | +7.9% |
| Q2 FY2024CQ3 2023 | Oct 31, 2023 | C$2.95M | +6.3% |
| Q1 FY2024CQ2 2023 | Jul 31, 2023 | C$2.80M | – |
| Q4 FY2023CQ1 2023 | Apr 30, 2023 | C$3.34M | – |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | C$2.96M | – |
| Q2 FY2023CQ3 2022 | Oct 31, 2022 | C$2.78M | – |
See a number that looks wrong?